Hubei Jumpcan Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Hubei Jumpcan Pharmaceutical has a total shareholder equity of CN¥13.4B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 8.1%. Its total assets and total liabilities are CN¥18.1B and CN¥4.8B respectively. Hubei Jumpcan Pharmaceutical's EBIT is CN¥2.9B making its interest coverage ratio -8.5. It has cash and short-term investments of CN¥10.9B.
Key information
8.1%
Debt to equity ratio
CN¥1.09b
Debt
Interest coverage ratio | -8.5x |
Cash | CN¥10.92b |
Equity | CN¥13.37b |
Total liabilities | CN¥4.77b |
Total assets | CN¥18.14b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 600566's short term assets (CN¥14.2B) exceed its short term liabilities (CN¥4.6B).
Long Term Liabilities: 600566's short term assets (CN¥14.2B) exceed its long term liabilities (CN¥183.0M).
Debt to Equity History and Analysis
Debt Level: 600566 has more cash than its total debt.
Reducing Debt: 600566's debt to equity ratio has reduced from 10.1% to 8.1% over the past 5 years.
Debt Coverage: 600566's debt is well covered by operating cash flow (318.5%).
Interest Coverage: 600566 earns more interest than it pays, so coverage of interest payments is not a concern.